HCA Healthcare, Inc. (NYSE:HCA – Get Free Report) has earned a consensus rating of “Moderate Buy” from the twenty-four research firms that are presently covering the firm, Marketbeat reports. One investment analyst has rated the stock with a sell rating, seven have given a hold rating and sixteen have issued a buy rating on the company. The average 12-month price target among analysts that have issued a report on the stock in the last year is $515.7727.
Several equities research analysts have issued reports on the stock. Oppenheimer cut their price objective on shares of HCA Healthcare from $540.00 to $520.00 and set an “outperform” rating for the company in a research report on Monday, April 27th. UBS Group increased their target price on shares of HCA Healthcare from $598.00 to $635.00 and gave the stock a “buy” rating in a research note on Monday, February 23rd. Cantor Fitzgerald reiterated an “overweight” rating on shares of HCA Healthcare in a report on Wednesday, March 4th. Leerink Partners reduced their target price on HCA Healthcare from $573.00 to $500.00 and set an “outperform” rating for the company in a research report on Monday, April 27th. Finally, Weiss Ratings downgraded HCA Healthcare from a “buy (b)” rating to a “buy (b-)” rating in a report on Monday.
Check Out Our Latest Analysis on HCA
HCA Healthcare Stock Up 0.5%
HCA Healthcare (NYSE:HCA – Get Free Report) last posted its quarterly earnings data on Friday, April 24th. The company reported $7.15 EPS for the quarter, missing the consensus estimate of $7.19 by ($0.04). HCA Healthcare had a net margin of 8.89% and a negative return on equity of 295.93%. The company had revenue of $19.11 billion during the quarter, compared to the consensus estimate of $19.09 billion. During the same period in the prior year, the firm posted $6.45 earnings per share. The company’s revenue was up 4.3% compared to the same quarter last year. HCA Healthcare has set its FY 2026 guidance at 29.100-31.500 EPS. Research analysts expect that HCA Healthcare will post 30.07 earnings per share for the current year.
HCA Healthcare Dividend Announcement
The business also recently announced a quarterly dividend, which will be paid on Tuesday, June 30th. Investors of record on Tuesday, June 16th will be issued a $0.78 dividend. The ex-dividend date is Tuesday, June 16th. This represents a $3.12 annualized dividend and a yield of 0.8%. HCA Healthcare’s dividend payout ratio (DPR) is currently 10.73%.
Hedge Funds Weigh In On HCA Healthcare
A number of institutional investors and hedge funds have recently made changes to their positions in HCA. Brighton Jones LLC bought a new stake in HCA Healthcare during the 4th quarter valued at $1,021,000. NewEdge Advisors LLC boosted its stake in shares of HCA Healthcare by 11.9% during the 1st quarter. NewEdge Advisors LLC now owns 3,859 shares of the company’s stock worth $1,334,000 after acquiring an additional 409 shares in the last quarter. Sivia Capital Partners LLC lifted its position in shares of HCA Healthcare by 5.5% during the 2nd quarter. Sivia Capital Partners LLC now owns 630 shares of the company’s stock valued at $241,000 after buying an additional 33 shares in the last quarter. Jump Financial LLC acquired a new stake in HCA Healthcare in the 2nd quarter valued at about $2,073,000. Finally, Sei Investments Co. grew its position in HCA Healthcare by 56.3% in the second quarter. Sei Investments Co. now owns 136,589 shares of the company’s stock worth $52,328,000 after acquiring an additional 49,214 shares during the period. 62.73% of the stock is owned by hedge funds and other institutional investors.
About HCA Healthcare
HCA Healthcare is a for‑profit operator of healthcare facilities headquartered in Nashville, Tennessee. Founded in 1968, the company owns and operates a network of hospitals and related healthcare facilities and has grown through organic expansion and acquisitions to become a large provider of inpatient and outpatient services.
The company’s core activities include the operation of acute care hospitals, freestanding surgical and emergency centers, and outpatient clinics. HCA’s services encompass inpatient care, surgical services, emergency medicine, diagnostic imaging and laboratory testing, and various outpatient and ambulatory care offerings.
Featured Stories
- Five stocks we like better than HCA Healthcare
- SpaceX IPO: Opportunity? Or the Ultimate Hype Trade?
- CAVA Group’s Stock Looks Delicious After Strong Earnings
- Lowe’s Finds Support at $215 After Q1 Earnings Sell-Off
- Deere Beats Q2 Estimates, But Ag Weakness Weighs on Outlook
Receive News & Ratings for HCA Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HCA Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.
